Pharma Journalist 7895 posts 0 comments

AQILION AB announced an exclusive license and strategic research collaboration with Merck to discover, develop and commercialize small molecule inhibitors of the transforming growth…
Read More...

Roche announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and…
Read More...

Evotec SE announced that the Company has extended and expanded its integrated multi-target drug discovery agreement with data-driven biotech creation firm, Related Sciences ("RS"), to…
Read More...

Takeda announced that it has completed an acquisition of all shares of Nimbus Lakshmi, Inc. (“Lakshmi”) from Nimbus Therapeutics, LLC (“Nimbus”), on February 8, 2023 (EST), as set forth…
Read More...

Vial, a technology-first CRO, has announced a partnership with Egnyte, a leader in cloud content security and governance, to integrate its Life Sciences eTMF (electronic trial master…
Read More...

IntelGenx Corp. announced a research collaboration with Per Svenningsson, MD, PhD, of the Karolinska Institute, to plan and conduct a multicentre, randomized, double-blind,…
Read More...

Mesoblast Limited announced that the United States Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT) has granted Regenerative Medicine Advanced…
Read More...

Creative Medical Technology Holdings, Inc., a biotechnology company working to revolutionize care through the development of potentially best-in-class regenerative therapeutics,…
Read More...

Regeneron Pharmaceuticals, Inc.announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA (aflibercept) Injection to treat preterm infants with retinopathy of…
Read More...

ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for cancer and other genetically-defined diseases, and Asieris Pharmaceuticals, a…
Read More...